Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Multimedia
June 08, 2016
Antimicrobial resistance (AMR) threatens future growth and prosperity, as well as health. Without global action, the UK's Review on Antimicrobial Resistance, led by Lord Jim O'Neill, estimates that an additional 10 million people will die every year from drug-resistant infections and the global econ...
TESTIMONY
April 08, 2016
On April 7, 2016, CGD’s vice president for programs and director of global health policy Amanda Glassman testified before the Senate Foreign Relations Subcommittee on Africa and Global Health Policy at a hearing examining progress made in addressing the West Africa Ebola epidemic and its s...
Blog Post
February 04, 2015
Six months have passed since the WHO declared the current outbreak of Ebola Virus Disease in West Africa a Public Health Emergency of International Concern. This declaration set in motion an international response to curb the spread of the disease. While far from over, there are signs that the epide...
Blog Post
November 19, 2014
The Obama Administration has requested $6.18 billion in emergency funding to fight and contain Ebola. The ask is now in the hands of Congress, but given that Ebola incidence seems to be on the decline in many (not all) districts in West Africa, some leaders are losing steam on the response...
BRIEFS
June 14, 2010
The Center for Global Development’s Drug Resistance Working Group urges pharmaceutical companies, governments, donors, global health institutions, health providers, and patients to collectively and immediately tackle this global health threat by implementing four key recommendations.